Page last updated: 2024-09-05

cp 113818 and Amyloid Deposits

cp 113818 has been researched along with Amyloid Deposits in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Domnitz, SB; Eckman, CB; Frosch, MP; Hofmeister, A; Hutter-Paier, B; Huttunen, HJ; Kim, DY; Kovacs, DM; Moir, RD; Puglielli, L; Windisch, M	1

Other Studies

1 other study(ies) available for cp 113818 and Amyloid Deposits

Article	Year
The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron, 2004, Oct-14, Volume: 44, Issue:2 Topics: Adrenal Glands; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Brain; Cholesterol Esters; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Learning; Male; Mice; Mice, Transgenic; Plaque, Amyloid; Pyridines; Sex Factors; Sterol O-Acyltransferase	2004

Article

Year

The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease.

Neuron, 2004, Oct-14, Volume: 44, Issue:2

Topics: Adrenal Glands; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Brain; Cholesterol Esters; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Learning; Male; Mice; Mice, Transgenic; Plaque, Amyloid; Pyridines; Sex Factors; Sterol O-Acyltransferase

2004